Internal Medicine in Newburyport, MA
23 verified internal medicine doctors in Newburyport.
Internists specialize in the prevention, diagnosis, and treatment of adult diseases, often coordinating complex or chronic conditions across multiple systems.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Massachusetts Board of Registration in Medicine
Dr. Stephen Beaudoin, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Anthony Eaton, MD
Internal Medicine
CMS Open Payments· $93.58 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$93.58
Total received
5
Transactions
5
Paying companies
Top paying companies
Among the 183,896 internal medicine doctors we've analyzed, about 37% received any industry payment (median $195 among those who did). This doctor's total ranks around the 75th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US internal medicine doctors.
Payments to Anthony Eaton do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Christopher Harris, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jessica Schoonmaker, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. William Ingram, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Saira Naseer, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kimberly Kersten, DO
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Alain-Marc Werner, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Viktoria Shvets, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Shih-Te Wen, MD
Internal Medicine
CMS Open Payments· $1,777 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,777
Total received
80
Transactions
20
Paying companies
Top paying companies
Among the 183,896 internal medicine doctors we've analyzed, about 37% received any industry payment (median $195 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US internal medicine doctors.
Payments to Shih-Te Wen do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Daniel Eyink, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Paul Mendelson, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Julie Geary, MD
Internal Medicine
CMS Open Payments· $1,014 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,014
Total received
71
Transactions
15
Paying companies
Top paying companies
Among the 183,896 internal medicine doctors we've analyzed, about 37% received any industry payment (median $195 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US internal medicine doctors.
Payments to Julie Geary do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Anthony Lopez, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Theresa Leak-Gonzalez, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mary Schwartz, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Hossam Yassin, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kay Ficht, MD
Internal Medicine
CMS Open Payments· $17.70 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$17.70
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 183,896 internal medicine doctors we've analyzed, about 37% received any industry payment (median $195 among those who did). This doctor's total ranks around the 65th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US internal medicine doctors.
Payments to Kay Ficht do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Lydia Jeffcoat, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Houtan Golzari, MD
Internal Medicine
CMS Open Payments· $3,038 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,038
Total received
178
Transactions
26
Paying companies
Top paying companies
Among the 183,896 internal medicine doctors we've analyzed, about 37% received any industry payment (median $195 among those who did). This doctor's total is higher than 96% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US internal medicine doctors.
Payments to Houtan Golzari do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Maria Ratchkova, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sai Kaza, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.